A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends...

Full description

Bibliographic Details
Main Authors: Ravit Bassal, Lital Keinan-Boker, Dani Cohen
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:https://www.mdpi.com/1660-4601/18/6/3070
id doaj-5b25606fa99f40139957b19be7d1154c
record_format Article
spelling doaj-5b25606fa99f40139957b19be7d1154c2021-03-17T00:05:50ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-03-01183070307010.3390/ijerph18063070A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 PandemicRavit Bassal0Lital Keinan-Boker1Dani Cohen2Israel Center for Disease Control, Ministry of Health, Sheba Medical Center, Ramat Gan 5262160, IsraelIsrael Center for Disease Control, Ministry of Health, Sheba Medical Center, Ramat Gan 5262160, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, IsraelSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends in the incidence of salmonellosis, shigellosis and campylobacteriosis in Israel during COVID-19 pandemic. Positive stool samples for <i>Salmonella</i>, <i>Shigella</i> and <i>Campylobacter</i> are reported on a monthly basis to the Israel Center for Disease Control from sentinel laboratories, within the framework of a surveillance network of bacterial culture-proven enteric diseases. Age-adjusted incidence rates per 100,000 of shigellosis, salmonellosis and campylobacteriosis were calculated. Mean rates before and after the local onset of COVID-19 pandemic in Israel were compared and Relative Risk Reduction (RRR) was calculated. Joinpoint was used to evaluate secular trends. The mean age-adjusted incidence rate of shigellosis in March–July 2020 was lower than the rate observed in March–July 2018–2019 (RRR = 86.6%), but also decreased for salmonellosis (RRR = 33.0%) and campylobacteriosis (RRR = 30.0%). Using Joinpoint we have shown that the decrease observed for shigellosis was significantly sharper (Annual Percent Change (APC) = −77.7) between February 2020 and May 2020 than for salmonellosis (APC = −14.0) between July 2019 and April 2020 and for campylobacteriosis (APC = −1.1) between January 2018 and July 2020. The preventive measures applied to reduce transmission of COVID-19, including social distancing and hand washing, were ecologically associated with a decreased risk of bacterial enteric diseases in Israel. The association was strongest for shigellosis, a disease that is mostly person-to-person transmitted, as compared to salmonellosis and campylobacteriosis which are mostly foodborne transmitted.https://www.mdpi.com/1660-4601/18/6/3070COVID-19outbreaktrendenteric diseasesincidence
collection DOAJ
language English
format Article
sources DOAJ
author Ravit Bassal
Lital Keinan-Boker
Dani Cohen
spellingShingle Ravit Bassal
Lital Keinan-Boker
Dani Cohen
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
International Journal of Environmental Research and Public Health
COVID-19
outbreak
trend
enteric diseases
incidence
author_facet Ravit Bassal
Lital Keinan-Boker
Dani Cohen
author_sort Ravit Bassal
title A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
title_short A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
title_full A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
title_fullStr A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
title_full_unstemmed A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
title_sort significant decrease in the incidence of shigellosis in israel during covid-19 pandemic
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1661-7827
1660-4601
publishDate 2021-03-01
description Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends in the incidence of salmonellosis, shigellosis and campylobacteriosis in Israel during COVID-19 pandemic. Positive stool samples for <i>Salmonella</i>, <i>Shigella</i> and <i>Campylobacter</i> are reported on a monthly basis to the Israel Center for Disease Control from sentinel laboratories, within the framework of a surveillance network of bacterial culture-proven enteric diseases. Age-adjusted incidence rates per 100,000 of shigellosis, salmonellosis and campylobacteriosis were calculated. Mean rates before and after the local onset of COVID-19 pandemic in Israel were compared and Relative Risk Reduction (RRR) was calculated. Joinpoint was used to evaluate secular trends. The mean age-adjusted incidence rate of shigellosis in March–July 2020 was lower than the rate observed in March–July 2018–2019 (RRR = 86.6%), but also decreased for salmonellosis (RRR = 33.0%) and campylobacteriosis (RRR = 30.0%). Using Joinpoint we have shown that the decrease observed for shigellosis was significantly sharper (Annual Percent Change (APC) = −77.7) between February 2020 and May 2020 than for salmonellosis (APC = −14.0) between July 2019 and April 2020 and for campylobacteriosis (APC = −1.1) between January 2018 and July 2020. The preventive measures applied to reduce transmission of COVID-19, including social distancing and hand washing, were ecologically associated with a decreased risk of bacterial enteric diseases in Israel. The association was strongest for shigellosis, a disease that is mostly person-to-person transmitted, as compared to salmonellosis and campylobacteriosis which are mostly foodborne transmitted.
topic COVID-19
outbreak
trend
enteric diseases
incidence
url https://www.mdpi.com/1660-4601/18/6/3070
work_keys_str_mv AT ravitbassal asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
AT litalkeinanboker asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
AT danicohen asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
AT ravitbassal significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
AT litalkeinanboker significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
AT danicohen significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic
_version_ 1724218991583428608